A growing population of over 10 million people worldwide with vision-threatening complications of diabetes and over 50 million people with ocular hypertension require treatments with retinal laser photocoagulators
The argon laser photocoagulator
was introduced commercially by Coherent in 1970 and based on the work of Dr.
The company's PASCAL product offerings include the original PASCAL Photocoagulator
, the PASCAL SlimLine[TM], the PASCAL Streamline[TM] and the Patterned Laser Trabeculoplasty (PLT) application.
OptiMedica's cataract program builds on a long history of innovation and market transformation, including the successful global commercialization of its patented PASCAL (PAttern SCAn Laser) Photocoagulator
The company holds the exclusive license to the PASCAL Photocoagulator
technology, which was originally developed at Stanford University.
Presentation Highlights: PASCAL Versus Conventional Photocoagulators
The PASCAL family of products also includes the PASCAL Photocoagulator
, OptiMedica's premier, fully integrated pattern scanning system.
OptiMedica's PASCAL Photocoagulator
system is currently distributed in major European markets by sister company Topcon Europe Medical.
In their new roles, Eno and Haddad are expected to help accelerate the global commercialization of OptiMedica's PASCAL([R]) (Pattern SCAn Laser) Photocoagulator
, a fully integrated pattern scan laser designed to treat a variety of retinal diseases.
Founded in 2004, OptiMedica has the exclusive worldwide rights to and has commercialized the groundbreaking PASCAL([R]) (PAttern SCAn Laser) Photocoagulator